BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11007709)

  • 1. Naltrexone treatment for a 3-year-old boy with self-injurious behavior.
    White T; Schultz SK
    Am J Psychiatry; 2000 Oct; 157(10):1574-82. PubMed ID: 11007709
    [No Abstract]   [Full Text] [Related]  

  • 2. Naltrexone and self-injurious behavior: a retrospective population study.
    Casner JA; Weinheimer B; Gualtieri CT
    J Clin Psychopharmacol; 1996 Oct; 16(5):389-94. PubMed ID: 8889912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of opiate antagonists for recurrent self-injurious behavior.
    Buzan RD; Thomas M; Dubovsky SL; Treadway J
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):437-44. PubMed ID: 8555746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone as a treatment of self-injurious behavior: a case report.
    Griengl H; Dantendorfer K
    Eur Psychiatry; 2001 Apr; 16(3):193-4. PubMed ID: 11353600
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities: Abridged republication of a Cochrane systematic review.
    Gormez A; Rana F; Varghese S
    J Psychopharmacol; 2014 Jul; 28(7):624-32. PubMed ID: 24785762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone treatment of self-injurious behavior.
    Godart NT; Agman G; Perdereau F; Jeammet P
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1076-8. PubMed ID: 10986803
    [No Abstract]   [Full Text] [Related]  

  • 7. Naltrexone as a treatment of self-injurious behavior--a case report.
    Griengl H; Sendera A; Dantendorfer K
    Acta Psychiatr Scand; 2001 Mar; 103(3):234-6. PubMed ID: 11240582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of naltrexone on self-injurious behavior.
    Sandman CA; Hetrick W; Taylor DV; Marion SD; Touchette P; Barron JL; Martinezzi V; Steinberg RM; Crinella FM
    Am J Ment Retard; 2000 Mar; 105(2):103-17. PubMed ID: 10755174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of naltrexone upon self-injurious behavior, learning and activity: a case study.
    Taylor DV; Hetrick WP; Neri CL; Touchette P; Barron JL; Sandman CA
    Pharmacol Biochem Behav; 1991 Sep; 40(1):79-82. PubMed ID: 1780350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate antagonists for recurrent self-injurious behavior in three mentally retarded adults.
    Buzan RD; Dubovsky SL; Treadway JT; Thomas M
    Psychiatr Serv; 1995 May; 46(5):511-2. PubMed ID: 7627682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone treatment of dementia with severe self-injurious behaviors: a single case study.
    Vance HB; Kauffmann C; Pumariega AJ; Del Mundo A
    Psychiatry; 2000; 63(3):288-99. PubMed ID: 11125673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cessation of long-term naltrexone therapy and self-injury: a case study.
    Crews WD; Bonaventura S; Rowe FB; Bonsie D
    Res Dev Disabil; 1993; 14(4):331-40. PubMed ID: 8210609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
    Roth AS; Ostroff RB; Hoffman RE
    J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of self-injury with phenytoin in a man with autism and intellectual disability: the role of frontal lobe seizures and catatonia.
    Coffey MJ
    J ECT; 2013 Mar; 29(1):e12-3. PubMed ID: 23422527
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
    Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
    Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Self-injurious-behavior in children and adolescents with intellectual disabilities].
    Rojahn J; Bienstein P
    Z Kinder Jugendpsychiatr Psychother; 2007 Nov; 35(6):411-22. PubMed ID: 18357971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical uses of naltrexone: a review of the evidence.
    Modesto-Lowe V; Van Kirk J
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone and fluoxetine in Prader-Willi syndrome.
    Benjamin E; Buot-Smith T
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):870-3. PubMed ID: 8340312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities.
    Aman MG
    Ann Clin Psychiatry; 1993 Sep; 5(3):171-88. PubMed ID: 7904217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral Treatment of Self-Injury: 2001 to 2016.
    Shawler LA; Russo SR; Hilton JL; Kahng S; Davis CJ; Dorsey MF
    Am J Intellect Dev Disabil; 2019 Sep; 124(5):450-469. PubMed ID: 31512946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.